IM Cannabis posts deeper loss as sales shrink by more than 40% over nine months

IM Cannabis Corp. is operating at a markedly reduced scale, according to unaudited interim accounts for the nine months to 30 September 2026. Revenue came to C$9.0m, down from C$15.8m in the same stretch of 2025, a fall of roughly 43%.

The net loss for the period was C$13.9m, larger than before. The company attributes part of the result to discontinued operations and to subsidiaries that have been deconsolidated. Its board signed off the statements on 13 November 2026.

The balance sheet has also shrunk. Total assets stood at C$13.7m, and the company reports a shareholders' deficit, meaning what it owes exceeds what it owns. It raised cash during the period through convertible notes and a private placement.

The material reviewed does not break revenue down by segment or geography, and it does not give the terms or sizes of the two financing routes. It is therefore unclear which parts of the business drove the decline, or how much each funding source contributed. Those details would be in the full filing.